COMMUNIQUÉS West-GlobeNewswire

Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026
19/06/2026
Global CRO expands its operational footprint into Singapore and Malaysia, strengthens China presence, and grows India operations - creating a powerhouse in the Asia Pacific region ADELAIDE, Australia, June 19, 2026 ( [...]
Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
19/06/2026
Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approval based on multiple studies, including the pivotal IRAKLIA phase 3 study which demonstrated non-inferior efficacy [...]
Communiqué de presse : Sanofi et HEC Paris lancent la « Sanofi MBA Life Sciences Scholarship » pour accompagner les futurs leaders de la santé
19/06/2026
Sanofi et HEC Paris lancent la « Sanofi MBA Life Sciences Scholarship » pour accompagner les futurs leaders de la santé Paris, le 19 juin 2026 — Sanofi et HEC Paris annoncent le lancement de la “ Sanofi MBA Life [...]
Arletta Pharma Solutions Appoints Steve van Os, MD, as Chief Medical Officer
19/06/2026
www.arlettapharmasolutions.com Seasoned biotech executive brings more than two decades of global clinical development, medical affairs and regulatory leadership across oncology, women’s health and endocrinology [...]
New European initiative to accelerate drug discovery for cardiometabolic diseases
19/06/2026
COPENHAGEN, Denmark, June 19, 2026 (GLOBE NEWSWIRE) -- The Novo Nordisk Foundation is funding a new pan-European initiative to accelerate drug discovery and the development of next generation therapeutics for [...]
Professor Mohamed Shamji Assumes Presidency of EAACI as Congress 2026 Concludes in Istanbul
19/06/2026
New leadership begins as the global allergy community advances the Vision Zero ambition of a future free from allergy and asthma burden ISTANBUL, June 19, 2026 (GLOBE NEWSWIRE) -- The European Academy of Allergy and [...]
Nutraville Expands Product Line with Pineal Guardian X, a Natural Brain Wellness Support
19/06/2026
Columbus, OH, June 19, 2026 (GLOBE NEWSWIRE) -- Nutraville, a natural wellness supplement brand, has launched Pineal Guardian X, a new dietary supplement designed to support brain wellness, mental clarity, daily focus, [...]
Kither Biotech successfully completes Phase 1 clinical trial of KIT2014, a novel inhaled peptide therapy for respiratory diseases
19/06/2026
First-in-human Phase 1 study in 56 healthy participants demonstrated KIT2014’s safety and tolerability KIT2014 is being developed as an inhalation therapy for respiratory diseases including chronic obstructive pulmonary [...]
Desert Hope Treatment Center Launches First Responder Lifeline Program, Offering Confidential Care for Frontline Heroes
19/06/2026
LAS VEGAS, June 18, 2026 (GLOBE NEWSWIRE) -- Desert Hope Treatment Center, a leading addiction treatment center in Las Vegas, has introduced its First Responder Lifeline Program, designed specifically for law [...]
Hi*Ball Energy fait son entrée au Royaume-Uni et redéfinit les codes de la boisson énergisante
18/06/2026
Faites le plein d’énergie autrement avec Hi*Ball Sparkling Energy Water, une boisson pétillante énergisante qui se veut audacieuse et sans compromis, composée de caféine naturelle et d’ingrédients fonctionnels, sans [...]
Autonomix Announces Reverse Stock Split
18/06/2026
THE WOODLANDS, TX, June 18, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
Memento Medicines Launches with $93 Million Series A Financing to advance Tie2 Agonist and VEGF Inhibitor Bispecific Antibody Therapy for Retinal Diseases
18/06/2026
Lead program, MMT-205, licensed from MabTics Co., Ltd / Curacle Co., Ltd. is a potential best-in-class bispecific antibody which activates Tie2 and inhibits VEGF, in development for neovascular age-related macular [...]
Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome
18/06/2026
NDA submission supported by positive Phase 3 data recently published in JAMA Neurology. Ecopipam is a first-in-class selective dopamine D1 receptor antagonist with a novel mechanism of action and has received FDA Orphan [...]
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/06/2026
WALTHAM, Mass., June 18, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Vireo Growth Inc. Completes Acquisition of Equity Interest in Maryland Dispensaries
18/06/2026
MINNEAPOLIS, June 18, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOD) (“Vireo” or the “Company”), today announced the closing of its previously announced acquisition to acquire an indirect 49% [...]
Teva Releases Q2 2026 Aide Memoire
18/06/2026
TEL AVIV, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2026 Aide Memoire is available on the “Investors” page on its website. Q2 2026 [...]
CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity
18/06/2026
CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that its wholly owned [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/06/2026
FOSTER CITY, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective June 17, 2026, it granted stock options to purchase [...]
Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET
18/06/2026
TEL AVIV, Israel and PARSIPPANY, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2026 financial [...]

Pages